Old Web
English
Sign In
Acemap
>
authorDetail
>
Nobuhiro Nakanishi
Nobuhiro Nakanishi
Mitsubishi Tanabe Pharma
Endocrinology
Canagliflozin
Teneligliptin
Internal medicine
Diabetes mellitus
3
Papers
69
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study
2018
Diabetes, Obesity and Metabolism
Takashi Kadowaki
Nobuya Inagaki
Kazuoki Kondo
Kenichi Nishimura
Genki Kaneko
Nobuko Maruyama
Nobuhiro Nakanishi
Maki Gouda
Hiroaki Iijima
Yumi Watanabe
Show All
Source
Cite
Save
Citations (21)
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
2017
Diabetes, Obesity and Metabolism
Takashi Kadowaki
Nobuya Inagaki
Kazuoki Kondo
Kenichi Nishimura
Genki Kaneko
Nobuko Maruyama
Nobuhiro Nakanishi
Hiroaki Iijima
Yumi Watanabe
Maki Gouda
Show All
Source
Cite
Save
Citations (37)
1